Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2012
10/03/2012CN101560177B Preparation method of atorvastatin calcium
10/03/2012CN101549013B Capsule, tablet and granules of minium and preparation method
10/03/2012CN101538314B Method for purifying Eptifibatide
10/03/2012CN101511852B Synthesis of diethyl{ i5'' (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs
10/03/2012CN101511377B Lipid-metabolism-ameliorating agent
10/03/2012CN101485671B Novel medicinal use of 8-O-acetyl shanzhiside methylester
10/03/2012CN101472597B Inhibitor of expression of nuclear transcription factor AP-1, and pharmaceutical product and product using the inhibitor
10/03/2012CN101450110B Artocarpus heterophyllus extract for treating cerebrovascular disease and preparation method thereof
10/03/2012CN101389624B 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
10/03/2012CN101361728B Salvianolic acid A injection and preparation method thereof
10/03/2012CN101284874B Peptide-based immunization therapy for treatment of atherosclerosis
10/03/2012CN101181283B Ant-ihemorrhoid pharmaceutical combination
10/02/2012US8278435 N-pyrazole A2A receptor agonists
10/02/2012US8278430 Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012US8278339 Valsartan salts
10/02/2012US8278329 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example
10/02/2012US8278291 Treatment of wrinkles and strias with 4-hydroxyandrostenedione or a derivative thereof
10/02/2012US8278275 Method to enhance hemodynamic stability using oxygen carrying compositions
10/02/2012US8278272 GLP-1, exendin-4, peptide analogs and uses thereof
10/02/2012US8278103 Oligonucleotides comprising alternating segments and uses thereof
10/02/2012US8278098 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/02/2012US8277372 Cardiac support device with differential compliance
10/02/2012CA2561601C Quaternary ammonium compound, process for producing the same, therapeutic agent for cerebrovascular disorder, and therapeutic agent for heart disease
10/02/2012CA2529453C Pyrrolidin-1,2-dicarboxylic acid-1-[(4-ethinyl-phenyl)-amide]-2-[(phenyl)-amide] derivative as inhibitors of coagulation factors xa and viia for the treatment of thromboses
10/02/2012CA2526636C Diaryl ureas for diseases mediated by pdgfr
10/02/2012CA2502531C Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
10/02/2012CA2484192C Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
10/02/2012CA2466477C A2b adenosine receptor antagonists
10/02/2012CA2453676C Thermotherapy via targeted delivery of nanoscale magnetic particles
10/02/2012CA2406393C Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
10/02/2012CA2321444C Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects
09/2012
09/27/2012WO2012128582A2 A COMPOUND FOR INHIBITING HUMAN 11-β-HYDROXY STEROID DEHYDROGENASE TYPE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
09/27/2012WO2012128502A2 Composition for promoting vasculogenesis comprising pauf
09/27/2012WO2012128082A1 Anti-mouse aggrus monoclonal antibody
09/27/2012WO2012127094A1 Isolated cells from the blood of the coronary sinus, and uses thereof
09/27/2012WO2012126472A1 Gaba-c receptor agonists or antagonists for use in the treatment of vascular diseases
09/27/2012WO2012126386A1 Mixed crystal agomelatine (form-viii), preparation method and use thereof and pharmaceutical composition containing same
09/27/2012WO2012126385A1 New crystal form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same
09/27/2012WO2012126280A1 Rutaecarpine compound, preparation method therefor, and use thereof
09/27/2012WO2012126275A1 Spiro-containing dihydropyrazole compounds
09/27/2012WO2012104263A3 1,4 oxazines as bace1 and/or bace2 inhibitors
09/27/2012US20120245552 Combination Therapy
09/27/2012US20120245217 RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
09/27/2012US20120245215 Co-Crystals of Pyrrolidinones
09/27/2012US20120245214 Slow infusion of sulcardine and its salts
09/27/2012US20120245213 Human type i taste receptor subunit 3 modulators and methods of using same
09/27/2012US20120245206 Multi-cyclic compounds and methods of use
09/27/2012US20120245203 Methods for treating heartburn and/or preventing gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
09/27/2012US20120245202 Methods and products for treating inflammation
09/27/2012US20120245195 Novel monohydrate of azaadamantane derivatives
09/27/2012US20120245191 New azaspirodecanone compounds
09/27/2012US20120245187 Heterobicyclic carboxamides as inhibitors for kinases
09/27/2012US20120245175 Mk2 inhibitors
09/27/2012US20120245172 Heterocyclic amine derivatives
09/27/2012US20120245171 Benzpyrazole derivatives as inhibitors of pi3 kinases
09/27/2012US20120245169 Certain chemical entities, compositions and methods
09/27/2012US20120245162 Oxadiazole inhibitors of leukotriene production
09/27/2012US20120245150 NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245149 NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245148 Tetrahydroquinoxaline uera derivatives, their preparation and their therapeutic application
09/27/2012US20120245147 Inhibitors of thapsigargin-induced cell death
09/27/2012US20120245144 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012US20120245134 Androgen pharmaceutical composition and method for treating depression
09/27/2012US20120245115 1-Methylnicotinaide Derivatives and Formulations of Treatment of Lipoprotein Abnormalities
09/27/2012US20120245110 Vascular leakage inhibitor
09/27/2012US20120245108 Method of modulating complement factor b (cfb) expression in cells
09/27/2012US20120245106 Modified lysine-mimetic compounds
09/27/2012US20120245092 Polypeptides having modulatory effects on cells
09/27/2012US20120245088 Compositions comprising igf1 agonists and uses thereof
09/27/2012US20120245083 Derivatives of CGRP
09/27/2012US20120244236 Composition having lipolysis-promoting effect
09/27/2012US20120244216 Coated pharmaceutical capsule dosage form
09/27/2012US20120244192 Sustained release formulations of peptidomimetic drugs and uses thereof
09/27/2012US20120244189 Treatment of infections
09/27/2012US20120244169 Treatment for Radiation-Induced Disorders
09/27/2012US20120244167 Antibodies to m-csf
09/27/2012US20120244152 Novel antagonist antibodies and their fab fragments against gpvi and uses thereof
09/27/2012US20120244149 Benzoxazepin pi3k inhibitor compounds and methods of use
09/27/2012US20120244139 Modified proteases that inhibit complement activation
09/27/2012US20120244136 Cardiac-Specific Protein Targeting Domain
09/27/2012CA2836007A1 Mouse anti-aggrus monoclonal antibodies
09/27/2012CA2829690A1 Mixed crystal agomelatine (form-viii), preparation method and use thereof and pharmaceutical composition containing same
09/27/2012CA2829687A1 New crystalline form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same
09/26/2012EP2502909A1 Aminopyridine derivative
09/26/2012EP2501695A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
09/26/2012EP2501678A1 Aryl-pyridine derivatives as aldosterone synthase inhibitors
09/26/2012EP2501399A2 Treatment of acute ischemic stroke or intracranial bleeding with tpa and carbamylated erythropoietin
09/26/2012EP2501398A1 Methods and pharmaceutical composition for the treatment of atherosclerosis
09/26/2012EP2501381A2 Treatment of atrial fibrillation
09/26/2012EP2501380A2 Slow infusion of sulcardine and its salts
09/26/2012EP2501378A1 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders
09/26/2012CN1764462B T-type calcium channel blockers
09/26/2012CN1738618B Pharmaceutical compositions and uses thereof
09/26/2012CN1662663B DNA enzyme to inhibit plasminogen activator inhibitor-1
09/26/2012CN102695512A Methods and systems for pharmacogenomic treatment of cardiovascular conditions
09/26/2012CN102690367A Preparation method of anti-atherosclerosis active laminarins
09/26/2012CN102690346A Polypeptide treating diabetes, its preparation method and application
09/26/2012CN102690308A Scutellarin-7-glycosyl derivatives, and preparation method and application thereof
09/26/2012CN102690278A Novel pyrimidine-fused cyclic compounds as cytokine inhibitors
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 1595